Phenotypic Correlates of Structural and Functional Protein Impairments Resultant from ALDH5A1 Variants
Authors:
Preprint
- 10 July 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective To investigate the genotype-to-protein-to-phenotype correlations of succinic semialdehyde dehydrogenase deficiency (SSADHD), an inherited metabolic disorder of γ-aminobutyric acid catabolism. Methods Bioinformatics and in silico mutagenesis analyses of ALDH5A1 variants were performed to evaluate their impact on protein stability, active site and co-factor binding domains, splicing, and homotetramer formation. Protein abnormalities were then correlated with a validated disease-specific clinical severity score and neurological, neuropsychological, biochemical, neuroimaging, and neurophysiological metrics. Results A total of 58 individuals (1:1 male/female ratio) were affected by 32 ALDH5A1 pathogenic variants, eight of which were novel. Compared to individuals with single homotetrameric or multiple homo and heterotetrameric proteins, those predicted not to synthesize any functional enzyme protein had significantly lower expression of ALDH5A1 (p = 0.001), worse overall clinical outcomes (p = 0.008) and specifically more severe cognitive deficits (p = 0.01), epilepsy (p = 0.04) and psychiatric morbidity (p = 0.04). Compared to individuals with predictions of having no protein or a protein impaired in catalytic functions, subjects whose proteins were predicted to be impaired in stability, folding, or oligomerization had a better overall clinical outcome (p = 0.02) and adaptive skills (p = 0.04). Conclusions The quantity and type of enzyme proteins (no protein, single homotetramers, or multiple homo and heterotetramers), as well as their structural and functional impairments (catalytic or stability, folding, or oligomerization), contribute to phenotype severity in SSADHD. These findings are valuable for assessment of disease prognosis and management, including patient selection for gene replacement therapy. Furthermore, they provide a roadmap to determine genotype-to-protein-to-phenotype relationships in other autosomal recessive disorders.Keywords
All Related Versions
- Version 1, 2023-07-10, Research Square
- Published version: Human Genetics, 142 (12), 1755.
This publication has 33 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Inherited disorders of gamma‐aminobutyric acid metabolism and advances in ALDH5A1 mutation identificationDevelopmental Medicine & Child Neurology, 2014
- GABA B -ergic motor cortex dysfunction in SSADH deficiencyNeurology, 2012
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiencyNeurology, 2009
- Redox‐switch modulation of human SSADH by dynamic catalytic loopThe EMBO Journal, 2009
- Cognitive Functioning and Survival in the Elderly: The SSADH C538T PolymorphismAnnals of Human Genetics, 2008
- Standard Mutation Nomenclature in Molecular DiagnosticsThe Journal of Molecular Diagnostics, 2007
- CUPSAT: prediction of protein stability upon point mutationsNucleic Acids Research, 2006
- Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiencyHuman Mutation, 2003